XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Capital Surplus [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Member]
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Capital Surplus [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2019 $ 88,966 $ 224,907 $ 296,760 $ 4,253 $ 614,886 $ 88,966 $ 224,907 $ 294,394 $ 4,253 $ 612,520
Balance (ASU 2016-13 [Member]) at Dec. 31, 2019               $ (2,366)   $ (2,366)
Balance (in shares) at Dec. 31, 2019 17,793,165         17,793,165        
Increase (Decrease) in Stockholders' Equity [Roll forward]                    
Net income     59,504   59,504          
Other comprehensive income (loss)       9,315 9,315          
Cash dividends declared     (27,160)   (27,160)          
Issuance of common stock $ 226 700     926          
Issuance of common stock (in shares) 45,341                  
Repurchase of common stock $ (163) (936)     (1,099)          
Repurchase of common stock (in shares) (32,664)                  
Issuance of restricted stock $ 108 (108)     0          
Issuance of restricted stock (in shares) 21,544                  
Vesting of restricted stock $ (85) 85     0          
Vesting of restricted stock (in shares) (16,985)                  
Stock-based compensation   859     859          
Balance at Dec. 31, 2020 $ 89,052 225,507 326,738 13,568 654,865          
Balance (in shares) at Dec. 31, 2020 17,810,401                  
Increase (Decrease) in Stockholders' Equity [Roll forward]                    
Net income     87,939   87,939          
Other comprehensive income (loss)       (18,416) (18,416)          
Cash dividends declared     (27,927)   (27,927)          
Issuance of common stock $ 205 760     965          
Issuance of common stock (in shares) 41,168                  
Issuance of restricted stock $ 46 (46)     0          
Issuance of restricted stock (in shares) 9,193                  
Vesting of restricted stock $ (88) 88     0          
Vesting of restricted stock (in shares) (17,681)                  
Stock-based compensation   776     776          
Balance at Dec. 31, 2021 $ 89,215 227,085 386,750 (4,848) $ 698,202          
Balance (in shares) at Dec. 31, 2021 17,843,081       17,843,081          
Increase (Decrease) in Stockholders' Equity [Roll forward]                    
Net income     81,814   $ 81,814          
Other comprehensive income (loss)       (124,304) (124,304)          
Cash dividends declared     (29,968)   (29,968)          
Issuance of common stock $ 271 770     1,041          
Issuance of common stock (in shares) 54,125                  
Issuance of restricted stock $ 252 (252)     0          
Issuance of restricted stock (in shares) 50,438                  
Vesting of restricted stock $ (147) 147     0          
Vesting of restricted stock (in shares) (29,364)                  
Stock-based compensation   1,262     1,262          
Balance at Dec. 31, 2022 $ 89,591 $ 229,012 $ 438,596 $ (129,152) $ 628,047          
Balance (in shares) at Dec. 31, 2022 17,918,280       17,918,280